ASPEED Technology Purchases IP from IPextreme Core Store
CAMPBELL, Calif. – April 29, 2008 – IPextreme®, Inc., the company bringing famous IP (intellectual property) to system-on-chip designers worldwide, today announced that ASPEED Technology Inc. in Hsinchu City, Taiwan has purchased Freescale’s ColdFire® V1 through IPextreme’s Core Store™ online marketplace. The ColdFire core will be used as an embedded processor in an upcoming ASIC product.
Designed for entry-level 32-bit applications, the V1 ColdFire core is a simplified version of the V2 ColdFire core. The small-footprint V1 core is designed to deliver increased system utilization, resulting in the lowest power consumption of any ColdFire MCU product to date, while offering more than ten times the performance of 8-bit MCUs.
The low-cost point of entry coupled with ColdFire’s proven track record make this core ideal for the Taiwanese embedded market.
“The V1 ColdFire core gives us great design flexibility using microcontroller technology proven over three decades,” said Chris Lin, president of ASPEED. “Making this purchase quickly and easily online, in a few simple steps, reduced the long sales cycle we usually anticipate when purchasing quality IP with proven architecture, which will help reduce our time-to-market.”
IPextreme markets the V1 through its Core Store marketplace (www.ip-extreme.com/corestore/), which opened in January 2008. By using IPextreme’s Core Store site, customers can browse and license ColdFire MCU cores with a few quick and easy clicks. Customers also may benefit from greater flexibility in choosing technical and service support packages through the Core Store site.
About ASPEED
ASPEED Technology Inc. is a highly innovative fabless company founded in November 2004 in Hsinchu City, Taiwan. The company devotes itself to providing silicon chips, silicon IP and silicon products that enable sophisticated SoC-centric multimedia, graphics and network applications. For additional information, please visit http://www.aspeedtech.com/index.html
About IPextreme Inc.
IPextreme packages, delivers and supports famous IP (intellectual property) designed by large semiconductor companies and used by system-on-chip (SoC) designers worldwide. These production-proven IP products serve both broad horizontal markets and specific verticals such as consumer and automotive, and are provided in a process-independent and EDA-neutral format for easy use by the widest range of customers. With a decade of experience in developing, packaging, licensing and supporting IP, IPextreme offers a complete business solution that allows semiconductor companies to strategically leverage their internal IP portfolio and expand overall revenue. The company has offices in Campbell, California; Munich, Germany; and Tokyo, Japan with representatives in India, Israel, Korea and Taiwan. For additional information, please visit www.ip-extreme.com.
|
||||||
Related News
- IPextreme Celebrates First Anniversary of Core Store
- IPextreme Breaks New Ground with Core Store
- Leading Aerospace and Defense Company purchases Interlaken IP core from Comcores
- 2026 All-Time High in Store for Global 300mm Semiconductor Fab Capacity After 2023 Slowdown, SEMI Reports
- Andes Technology's N25F RISC-V Processor Enables Superior Immersive Scenarios for ASPEED Technology's Powerful Image Stitching SoC AST1230
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
|
|
E-mail This Article |
|
Printer-Friendly Page |






